Pharma Commons
  • Home
  • About
  • Company List
  • Contact

Genentech | Pharma Commons 2012-07-09 07:00:00

July 9, 2012 BioSpace.com Featured News Genentech
When Roche paid $46.8 billion in 2009 to gain full ownership of Genentech, fears were rife that the arrival of the Swiss men in suits would stifle the free-wheeling innovative culture at the Californi…
Read the full story: BioSpace.com Featured News

Post navigation

Lilly gets extra six months exclusivity for Cymbalta
Rival sources tangle over claim that Celgene is mulling ‘horrid’ HGS bid

Receive a daily news digest

Enter your email address:

Search the archive

Search for:

Company list

Browse by tags

Abbott abbott laboratories Amgen astrazeneca astrazeneca plc Bayer biogen idec boehringer ingelheim breast cancer bristol myers bristol myers squibb bristol myers squibb company cancer drug diabetes drug eli lilly eli lilly and company food and drug administration genepool gilead sciences gilead sciences inc glaxosmithkline glaxosmithkline plc gsk latest biotech news Lilly lilly and company london reuters Merck merck kgaa merck serono Myers Nordisk Novartis novartis ag novo nordisk pfizer pfizer inc Pharma PLC PRNewswire reuters Roche roche holding ag rsquo sanofi
dazzling Theme by Colorlib Powered by WordPress